Does adjuvant therapy improve overall survival for stage IA/B pancreatic adenocarcinoma?

BACKGROUND: Current guidelines recommend adjuvant chemotherapy for resected pancreatic adeno-carcinoma (PDAC). However, no studies have addressed its survival benefit for stage I patients as they comprise <10% of PDAC. METHODS: Using the NCDB 2006–2012, resected PDAC patients with stage I disease...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:HPB (Oxford)
Autores principales: Ostapoff, Katherine T., Gabriel, Emmanuel, Attwood, Kristopher, Kuvshinoff, Boris W., Nurkin, Steven J., Hochwald, Steven N.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2017
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6324176/
https://ncbi.nlm.nih.gov/pubmed/28433254
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.hpb.2017.03.002
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares